We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| TransMedics Group Inc | NASDAQ:TMDX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.06 | 1.58% | 132.04 | 131.90 | 132.81 | 132.50 | 128.15 | 129.97 | 645,176 | 01:00:00 |
From May 2021 to May 2024
By Matt Grossman
TransMedics Group Inc. shares have had trading halted on the Nasdaq ahead of a regulatory meeting that will review one of the company's products.
The Food and Drug Administration's panel for gastroenterology and urology devices will meet at 9 a.m. ET to discuss TransMedic's liver system, a portable device designed to preserve a donated liver prior to transplant.
Shares of Andover, Mass.-based TransMedics fell by 5.3% on Tuesday, to close at $31.69.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 14, 2021 07:34 ET (11:34 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year TransMedics Chart |
1 Month TransMedics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
